S Wergeland Selected Research

linolenic acid drug combination linoleic acid

1/2012

Polyunsaturated fatty acids in multiple sclerosis therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Wergeland Research Topics

Disease

8	Multiple Sclerosis 01/2018 - 03/2005
2	Relapsing-Remitting Multiple Sclerosis 01/2016 - 03/2005
1	Autoimmune Diseases of the Nervous System 01/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2012
1	Hepatitis C 03/2005

Drug/Important Bio-Agent (IBA)

4	Vitamin D FDA LinkGeneric 01/2018 - 01/2013
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018 - 01/2016
1	hydroxide ionIBA 01/2016
1	25-hydroxyvitamin DIBA 01/2016
1	EBV-encoded nuclear antigen 1IBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2016
1	Biological ProductsIBA 01/2015
1	VitaminsIBA 01/2013
1	alpha-Tocopherol FDA Link 01/2013
1	Retinaldehyde (Retinal)IBA 01/2013
1	Vitamin A (Retinol)FDA LinkGeneric 01/2013
1	Carotenoids (Carotene)IBA 01/2013
1	Vitamin K FDA Link 01/2013
1	Vitamin E FDA LinkGeneric 01/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2012
1	Docosahexaenoic AcidsIBA 01/2012
1	CuprizoneIBA 01/2012
1	Eicosapentaenoic AcidIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	linolenic acid drug combination linoleic acidIBA 01/2012
1	InterferonsIBA 03/2005
1	Interleukin-10 (Interleukin 10)IBA 03/2005

Therapy/Procedure

2	Therapeutics 01/2015 - 01/2012